Literature DB >> 22893884

Septic arthritis and osteomyelitis due to the chromoblastomycosis agent Fonsecaea pedrosoi.

Leonidiz De Guzman1, David C Perlman, Christopher E Hubbard.   

Abstract

Fonsecaea pedrosoi is the most common agent of chromoblastomycosis, a chronic localized fungal infection of the skin and subcutaneous tissues mainly involving the lower extremities. We report a rare case of septic arthritis and osteomyelitis due to the chromoblastomycosis agent F pedrosoi, which was successfully treated with arthrotomy and debridement, followed by a long course of oral antifungal therapy. To our knowledge, this is the second case of F pedrosoi osteomyelitis treated successfully to be ever reported.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893884

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  4 in total

1.  Arthrocladium fulminans Arthritis and Osteomyelitis.

Authors:  Abdoulahy Diallo; Céline Michaud; Souandou Tabibou; Maxime Raz; Carla Fernandez; Hubert Lepidi; Pierre-Edouard Fournier; Andreas Stein; Stéphane Ranque; Piseth Seng
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 2.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Hidden under a Cauliflower-Like Skin Tumor: Chromoblastomycosis.

Authors:  B Jakopp; B Stamm; D Eyer; A Conen
Journal:  Case Rep Infect Dis       Date:  2013-06-20

4.  Chromoblastomycosis Associated with Bone and Central Nervous Involvement System in an Immunocompetent Child Caused by Exophiala Spinifera.

Authors:  Sahana M Srinivas; Vykuntaraju K Gowda; S Mahantesh; Rajeshwari Mannapur; Sanjay K Shivappa
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.